Remove 2024 Remove Clinical Trials Remove Treatment
article thumbnail

CBD Topical Medicine: What Does the Science Say?

Project CBD

Clinical benefits? A May 2024 article in the International Journal of Molecular Sciences assesses efforts thus far using CBD to treat inflammatory pain (such as in arthritis) via transdermal delivery systems. New clinical trials are urgently needed, they repeat in a familiar refrain. So what do the studies say?

article thumbnail

Medical Cannabis and Anxiety: Natural Treatment Options

Miss Marijuana

But here’s something interesting: a recent study from 2024 showed that 78% of people using medical cannabis saw a major drop in anxiety within just a month! Clinical trials have been looking into both THC and CBD and their individual roles in treating anxiety. Feeling like anxiety’s got you pinned down? But high doses?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

RYAH Medtech Inc. Completes Initial Shipment for Major UK-based Clinical Trial

Cannabis Law Report

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. billion, servicing nearly 340,000 active patients.

article thumbnail

A Bipartisan Bill Is Pledging $75 Million for Psychedelic Research in Military PTSD Treatment

Veriheal

Recognizing that the efficacy of treatment relies not only on the therapeutic substances themselves but also on the skill and knowledge of the individuals administering them, this bill explicitly supports the training of practitioners. Nancy Mace (R-SC), Matt Gaetz (R-FL), and Jack Bergman (R-MI) representing the Republican party.

article thumbnail

Press Release: Silo Pharma Secures Patent that May be Used for Psychedelics Delivery Technology

Cannabis Law Report

Silo Pharma’s notice of allowance paves the way toward clinical trials for its psychedelics delivery platform using homing peptides. According to Global Industry Analysts , the global CNS therapeutics market could reach more than $132 billion by 2024. Silo Pharma Inc. Looking to the Future. Silo Pharma Inc.

article thumbnail

Awakn Life Sciences Begins Trading On NEO

Cannabis Law Report

The company’s target is 20 clinics by the end of 2024. “The NEO listing will enable us to accelerate the execution of our drug discovery, therapy development, advanced analytics, and open clinic rollout programs.”. Celia Morgan). David Nutt), starts in Q4 2021.

article thumbnail

Medical Marijuana for Cancer Treatment: Complete Patient Guide (2025)

Miss Marijuana

A 2024 study found that 67% of cancer patients using medical marijuana saw major improvements in their quality of life. Whether it’s easing pain or fighting nausea, cannabis is becoming a game-changer for cancer treatment. Ongoing research is diving deep into how cannabis can help people going through cancer treatment.